Cardior Pharmaceuticals
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
Hanover, Germanycardior.de ↗
Total raised
€64M
€64,000,000
Funding rounds
1
Investors
9
distinct backers
Active since
2021-08
latest 2021-08
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood17
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-08-25 | Series B | €64M | BioMedPartners,Bristol Myers Squibb,Coparion,Fund plus,Hadean Ventures,High-Tech Gründerfonds+3 more | View deal → |
Investors
9Related news
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software